Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000032

Options or other derivatives

  • Chief Corp Dev & Strategy acquired 66,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Viswanadhan Krishnan · Chief Corp Dev & Strategy

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-01 Grant or award : show line 1 in the form 10b5-1 Restricted stock units +14,000 14,000 D
2026-03-01 Grant or award : show line 2 in the form 10b5-1 Stock options (right to buy) +52,000 52,000 D
Loading xslF345X05/wk-form4_1772572279.xml…